Literature DB >> 14476340

Anti-nuclear factors and serum complement in systemic lupus erythematosus.

J H MORSE, H J MULLER-EBERHARD, H G KUNKEL.   

Abstract

Entities:  

Keywords:  LUPUS ERYTHEMATOSUS/immunology

Mesh：

Substances：

Year:  1962        PMID： 14476340      PMCID： PMC1804852     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  20 in total

1.  Latex agglutination test for disseminated lupus erythematosus.

Authors:  C L CHRISTIAN; R MENDEZ-BRYAN; D L LARSON
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

2.  The L. E. cell and the L. E. serum factors.

Authors:  H R HOLMAN; H R DEICHER; H G KUNKEL
Journal:  Bull N Y Acad Med       Date:  1959-07

3.  Studies on the L. E.-cell phenomenon.

Authors:  W HIJMANS; H R SCHUIT
Journal:  Vox Sang       Date:  1958-05       Impact factor: 2.144

4.  Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein.

Authors:  H R HOLMAN; H G KUNKEL
Journal:  Science       Date:  1957-07-26       Impact factor: 47.728

5.  A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus.

Authors:  R CEPPELLINI; E POLLI; F CELADA
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

6.  Complement fixation with cell nuclei and DNA in lupus erythematosus.

Authors:  W C ROBBINS; H R HOLMAN; H DEICHER; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

7.  [Absorption of L. E. factor by isolated cell nuclei].

Authors:  P MIESCHER; M FAUCONNET
Journal:  Experientia       Date:  1954-06-15

8.  Complement components in the sera and urines of patients with severe proteinurias.

Authors:  K LANGE; E J WENK
Journal:  Am J Med Sci       Date:  1954-10       Impact factor: 2.378

9.  The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone therapy in lupus erythematosus disseminatus.

Authors:  J H VAUGHAN; T B BAYLES; C B FAVOUR
Journal:  J Lab Clin Med       Date:  1951-05

10.  Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction.

Authors:  R C MELLORS; L G ORTEGA; H R HOLMAN
Journal:  J Exp Med       Date:  1957-08-01       Impact factor: 14.307
View more
  23 in total

1.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Authors:  C D WEST; J D NORTHWAY; N C DAVIS
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  Systemic lupus erythematosus. Cryoprecipitation of sera.

Authors:  C L CHRISTIAN; W B HATFIELD; P H CHASE
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

3.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 4.  Complement cascade and kidney transplantation: The rediscovery of an ancient enemy.

Authors:  Alberto Mella; Maria Messina; Antonio Lavacca; Luigi Biancone
Journal:  World J Transplant       Date:  2014-09-24

5.  Complement components in three pathological sera: relation to clinical states.

Authors:  A B Laurell; B Lundh; J Malmquist; R Siboo
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

6.  [The significance of the beta 1C-1A content in serum of patients with the so-called "lupoid" hepatitis].

Authors:  C Mueller-Eckhardt; G Kretzschmar; H A Kühn
Journal:  Klin Wochenschr       Date:  1970-04-15

7.  Examination of complement C3 metabolism in rheumatoid arthritis using 2-dimensional immunoelectrophoresis.

Authors:  M F Shadforth; D C McNaughton
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

8.  Effect of ageing of serum on consumption of antibody by beta-1C-globulin determinants; evidence for circulating breakdown products in glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; N C Davis
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

9.  Complement (C3) metabolism in rheumatoid arthritis in relation to the disease course.

Authors:  A J Swaak; H Han; A van Rooyen; M Pillay; C E Hack
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

10.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.